Explore the Global Rare Neurological Disease Treatment Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Rare Neurological Disease Treatment Market

Key Insight

Oral formulations represent 72.0% of the route of administration category and adult patients account for 58.0% of patient type demand in 2026. The rare neurological disease treatment market was valued at USD 20.0 billion in 2025 and is forecast to post a 7.4% CAGR between 2026 and 2036.

June 02, 2026

Anurag Sharma

385 Pages

Cite this Report

Rare Neurological Disease Treatment Market

https://www.futuremarketinsights.com/reports/rare-neurological-disease-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Competitive Analysis

Key Players

Biogen Inc
Gene Therapy Sponsors
IntraBio Inc
Ionis Pharmaceuticals Inc.
Novartis
PTC Therapeutics Inc
Sarepta Therapeutics Inc
Zevra Therapeutics Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Rare Neurological Disease Treatment Market

Key Players

Similar Industry Reports